|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Acquired in-process research and development | |||||
| Selling, general and administrative | |||||
| Impairment and restructuring charges | |||||
| Impairment charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Interest and other income (expense), net: | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Other income (expense), net | |||||
| Total interest and other income (expense), net | |||||
| Loss before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Net loss per common share, basic (in USD per share) | |||||
| Net loss per common share, diluted (in USD per share) | |||||
| Weighted-average shares, basic (in shares) | |||||
| Weighted-average shares, diluted (in shares) |
Loading...
